课题基金 / 基金详情

SPORE University of Texas M. D. Anderson Cancer Center-Leukemia

SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
SPORE 德克萨斯大学 MD 安德森癌症中心 - 白血病
批准号:
10911713
负责人:
Elizabeth J Shpall
金额:
$91.86万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-01 至 2024-08-31
关键词:
ATAC-seqAchievementActivated Natural Killer CellAcute Myelocytic LeukemiaAcute leukemiaAddressAdministratorAdoptive TransferAdvocateAftercareAllogenicAntigensAwardAzacitidineB lymphoid malignancyBCL1 OncogeneBCL2 geneBiological MarkersBloodBlood ProteinsBone MarrowCAR T cell therapyCASP9 geneCD28 geneCD70 antigenCancer CenterCancer Center Support GrantCaringCell DeathCell Differentiation processCell LineCell ProliferationCell ShapeCell SurvivalCell TherapyCell physiologyCellsCellular StressChIP-seqChemoresistanceChromatinClinicClinicalClinical ProtocolsClinical TrialsCollaborationsCommunicationComplementComplexConsultationsCryopreservationCytarabineCytoplasmDNADataDatabasesDependenceDevelopmentDiseaseDisease remissionDoctor of MedicineDoseDoxorubicinDrug TargetingEZH2 geneElectronic MailEligibility DeterminationEndogenous RetrovirusesEndowmentEngineeringEnrollmentEnsureEventExhibitsExposure toFLT3 inhibitorFutureGene SilencingGenerationsGenesGenetic TranscriptionGenotypeGoalsGood Manufacturing ProcessGrantHematologic NeoplasmsHematopoietic stem cellsHodgkin DiseaseHumanIL3RA geneIn VitroIn complete remissionInduction of ApoptosisInfrastructureInstitutionInstitutional Review BoardsInterferonsInterleukin-15LaboratoriesLeukemic CellLigandsLiposomesLymphoid CellMaintenanceMarrowMeasuresMetabolicMetabolismMethodsMinorityMitochondrial Electron Transport Complex IModalityModelingMonitorMorphologyMultiple MyelomaMusMutationNational Cancer InstituteNatural Killer CellsNatureNeoadjuvant TherapyOncogenesOrganOutcomeOxidative PhosphorylationPathogenesisPathologicPathologyPatientsPharmaceutical PreparationsPhasePhase I Clinical TrialsPhase I/II Clinical TrialPhenotypePhosphorylation InhibitionPlayPoliciesPopulationPostremission TherapyPreclinical TestingPredispositionPreparationPrognosisProgress ReportsProliferatingProtein ArrayProteomicsProtocols documentationPublicationsPublishingRNARefractoryRegulationRelapseRelaxationReportingReproduction sporesResearchResearch PersonnelResearch Project GrantsResidual NeoplasmResidual stateResistanceRetrotransposonRiskSafetySamplingSerumSignal TransductionSiteSpecimenStem cell transplantStrategic PlanningStressT-LymphocyteTNF geneTestingTexasTherapeuticTissuesToxic effectTranscription ElongationTranscription InitiationTranslational ResearchTreatment EfficacyTumor AntigensTumor BurdenUmbilical Cord BloodUnited States National Institutes of HealthUniversitiesUniversity of Texas M D Anderson Cancer CenterUp-RegulationWomanWorkacute myeloid leukemia celladverse outcomeantileukemic activitybiobankbiological adaptation to stresscareercell killingcellular transductionchemotherapeutic agentchemotherapychimeric antigen receptorcohortcostcytopeniadesigndrug developmentdrug testingds-DNAefficacy testingengineered NK cellexperienceexperimental studyfirst-in-humangenetically modified cellsgraft vs host diseaseimprovedimproved outcomein vitro activityin vitro testingin vivoinhibitorinhibitor therapylecturesleukemialeukemia relapseleukemia treatmentleukemic stem celllymphoid neoplasmmanufacturemanufacturing processmeetingsmembermesenchymal stromal cellmetabolic fitnessmitochondrial fitnessmouse modelnanomolarneoplastic cellnext generationnovelnovel therapeuticsolder patientoverexpressionpartial responsepatient derived xenograft modelperipheral bloodpharmacodynamic biomarkerpharmacologicpoint of carepreventprogenitorprogramsprospectiveprotein expressionreceptorrecruitrelapse patientsrepositoryresponsescreeningsensorsingle cell analysissmall moleculestandard carestem cellssuccesssuicide genesymposiumsynergismtargeted therapy trialstooltranscriptome sequencingtranscriptomicstransplantation therapytumortumor heterogeneityvectorweaponsweb site

项目摘要

项目成果

Elizabeth J Shpall的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 不适用
英文摘要
Project Abstract N/A
期刊论文(634)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.hoc.2010.02.007
发表时间: 2010-04
期刊: Hematology/oncology clinics of North America
影响因子: --
作者: [Issa JP]
通讯作者: Issa JP
DOI: 10.18632/oncotarget.1292
发表时间: 2013-10
期刊: Oncotarget
影响因子: --
作者: [Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, Buiga R, Pop V, Irimie A, Fodde R, Bedrosian I, Martens JW, Foekens JA, Berindan-Neagoe I, Calin GA]
通讯作者: Calin GA
DOI: 10.1002/cncr.23691
发表时间: 2008-09-15
期刊: CANCER
影响因子: 6.2
作者: [Tsimberidou, Apostolia-Maria, Kantarjian, Hagop M., Wen, Sijin, Keating, Michael J., O'Brien, Susan, Brandt, Mark, Pierce, Sherry, Freireieh, Emil J., Medeiros, L. Jeffrey, Estey, Elihu]
通讯作者: Estey, Elihu
DOI: 10.1038/nature11016
发表时间: 2012-04-15
期刊: NATURE
影响因子: 64.8
作者: [Smith, Catherine C., Wang, Qi, Chin, Chen-Shan, Salerno, Sara, Damon, Lauren E., Levis, Mark J., Perl, Alexander E., Travers, Kevin J., Wang, Susana, Hunt, Jeremy P., Zarrinkar, Patrick P., Schadt, Eric E., Kasarskis, Andrew, Kuriyan, John, Shah, Neil P.]
通讯作者: Shah, Neil P.
共 374 条
    Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD
    Cord Blood Expansion and Homing to Improve Engraftment
    Administrative Core
    Cord Blood Expansion and Homing to Improve Engraftment
    海外基金